Treatment of heparin-induced thrombocytopenia

Thromb Haemost. 1999 Aug;82(2):457-67.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Ancrod / immunology
  • Ancrod / therapeutic use
  • Antibodies
  • Anticoagulants / adverse effects*
  • Anticoagulants / immunology
  • Anticoagulants / therapeutic use
  • Antigen-Antibody Complex
  • Antithrombins / immunology
  • Antithrombins / therapeutic use*
  • Child
  • Chondroitin Sulfates / immunology
  • Chondroitin Sulfates / therapeutic use
  • Cross Reactions
  • Dermatan Sulfate / immunology
  • Dermatan Sulfate / therapeutic use
  • Drug Combinations
  • Extracorporeal Circulation
  • Female
  • Heparin / adverse effects*
  • Heparin / immunology
  • Heparitin Sulfate / immunology
  • Heparitin Sulfate / therapeutic use
  • Hirudin Therapy
  • Hirudins / immunology
  • Humans
  • Platelet Factor 4 / immunology
  • Pregnancy
  • Pregnancy Complications, Hematologic
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / immunology
  • Thrombolytic Therapy
  • Thrombosis / chemically induced
  • Thrombosis / drug therapy

Substances

  • Antibodies
  • Anticoagulants
  • Antigen-Antibody Complex
  • Antithrombins
  • Drug Combinations
  • Hirudins
  • Dermatan Sulfate
  • Platelet Factor 4
  • Heparin
  • Chondroitin Sulfates
  • Heparitin Sulfate
  • danaparoid
  • Ancrod